EP-1404: Photon energy response of TNRD neutron detector in a Co- 60 irradiator and a 6 MV clinac  by Terrón, J.A. et al.
3rd ESTRO Forum 2015                                                                                                                                         S757 
 
increasingly used for dosimetric verification. We have 
investigated the use of the TheraView CCD camera-based 
EPID for transmit dosimetry and developed a calibration 
method using the PTW OCTAVIUS 2D array of ion chambers. 
Materials and Methods: In order to use TheraView EPID for 
dosimetric purposes, several preliminary tests have been 
done, including the need for extra build-up thickness, 
stability, short and long-terms reproducibility, dose history, 
linearity, and output factor measurements. In order to 
predict patient-transmitted dose map, acquired electronic 
portal image (EPI) pixel values were converted to dose by a 
fourth order polynomial regression model. To correct EPIs, 
the off-axis ratio of dose profiles measured by EPID and 2D 
array detector were used to derive correction factor matrices 
(CFMs). Crosstalk effect and non-uniformity of EPI due to the 
45º tilted mirror have been reported in other studies, 
corrected by the CFM. To speed up this process, an in-house 
program called SBUDose was developed. The program 
automatically performs these tasks and generates a report. 
Results: The corrected relative dose maps acquired for 
different conditions, measured using the EPID were compared 
with the 2D array detector images using a gamma function 
algorithm. In each case, more than 90% of points fell within 
3% of the maximum dose and 3 mm distance to agreement. 
Conclusions: We have found that TheraView fluoroscopic 
EPID can be accurately calibrated for in-vivo dosimetry.  
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Purpose/Objective: The study was aimed to check treatment 
accuracy and definition of action levels during clinical 
implementation of in vivo dosimetry as a part of quality 
assurance program. Treatment accuracy was quantified as 
the ratio of the measured dose at accelerator and the 
expected dose from the treatment planning system (TPS). 
Materials and Methods: Calibration and corrections factors 
for in vivo entrance dose measurements for semiconductor 
diodes were determined as recommended by ESTRO Booklet 
No.5. The patients were divided in categories according to 
tumor localization, patient immobilization and irradiation 
technique used, in order to investigate and detect the groups 
for which the uncertainty was larger or for which a 
systematic error occurred. The tolerance level assessments 
for different patient groups were determined. Initial 
tolerance level of 5% was applied for all fields. 
Results: In this study, entrance dose measurements were 
performed for total 451 treatment fields, of 338 patients 
over one year period. The mean value and the standard 
deviation for different groups were: Breast: 
+1.0%±2.89%(1SD), Brain and head and neck: 
+0.74%±2.04%(1SD), Isocentric pelvis and abdomen: 
+0.1%±2.86%(1SD), All measurements: +0.72%±2.64%(1SD). 
Deviations larger than 5% were detected in 19 cases (4.3%) of 
all measurements and most of them, 16 cases (84%), were 
detected for breast treatment site. The tolerance level for 
brain and head and neck site was changed to 4%, for breast 
site was changed to 6% and for isocentric pelvis and abdomen 
site tolerance level was kept at initial level of 5%.  
Conclusions: In our experience, systematic in vivo dosimetry 
proved to be a very useful tool for quality assurance of a 
patient plan and treatment, both in detecting systematic 
errors and for estimating the accuracy of treatment delivery. 
Correct assessment of tolerance levels should minimize the 
number of repeats required and give the full confidence that 
patients are being treated as planned.  
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Purpose/Objective: The validation of a novel digital thermal 
neutron detector TNRD has been carried out for clinical 
applications. The results obtained by our group, indicated 
that the estimation of neutron doses, both in phantom and 
patients are perfectly feasible with this detector [1]. 
Although differences among the two diodes that compose the 
detectors in terms of photon sensitivity were reduced in the 
manufacturing process, experiments have shown them not to 
be completely reliable in some special clinical environment. 
The goal would be to find a relation between dose-signal 
responses with photon dose and energy, in order to establish 
TNRD limitations in clinical environments.  
Materials and Methods: The 60Co photon source used is a 
Gammabeam® X200 irradiator, that provides gamma photons 
(with energies of 1.17 and 1.33 MeV) in a wide range of dose 
rate (0.05-400 Gy/h), obtained with different attenuation 
systems. The linac used is a Primus Siemens with 6 MV and a 
40x10 cm2 field. Measurements were performed with a PTW 
Farmer ionization chamber and Thermal Neutron Rate 
Detector (TNRD), based on a pair of photodiodes and 
sensitized to thermal neutrons [2]. Pure photon response of 
TNRD was studied in the 60Co facility for dose rates ranging 
from 0 to 4 cGy/min. As we have already confirmed that 
neutron presence in 6 MV is negligible, measurements ranging 
from 0.1 to 4.6 cGy photon doses were performed for 
different out-of-field detector positions.  
Results: Although we expected to obtain a constant signal-
dose relation for TNRD, different behavior was observed at 
both facilities. A higher reading is obtained always for the 
60Co measurements, being almost 7 times bigger for low doses 
(0.12 cGy) and around 3 times at higher ones (4.3 cGy). TNRD 
energy response, can be estimated based on the mass-energy 
attenuation coefficient (µen/ρ) of 14Si (main component of 
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TNRD detector) shown in the figure. The difference found in 
TNRD signal in 60Co and 6 MV (table) is justified by the higher 
response observed for the 14Si at low energies, taking into 
account that measurements are always performed in a 
peripheral area where scattering is dominant and thus mean 
energy lower. 
 
Figure. Logarithmic representation of the μen/ρ coefficient 
for 14Si in the range of 0-20 MeV, data extracted from: 
http://physics.nist.gov/PhysRefData/XrayMassCoef/ElemTab
/z14.html. 
Table. (See text) 
 
 
Conclusions: TNRD neutron detector has shown to be 
sensitive to photon dose rates even at low values (0.15-4 
cGy/min). Different behaviour has been noticed for 60Co and 
6 MV photon energies. Nevertheless, similar TNRD response to 
6 and 15 MV photons could be expected. In consequence, in 
order to reasonably avoid photon presence in peripheral 
neutron estimations, the subtraction of 6 MV signal to the 15 
MV one (under the same irradiation conditions) could be a 
good approximation. Further measurements and MC 
simulations, should be necessary to ensure this proposal for 
different linac energies. 
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Purpose/Objective: To study the dosimetric properties of 
TLD2000 thermoluminescent dosimeter (TLD), including 
repeatability, linearity of dose response, energy response and 
dose rate effect. 
Materials and Methods: 1300 TLD2000 TLDs were read out 
after exposure to a dose of 1 mGy of 65 keV x-ray, then were 
sorted out to have the same sensitivity within ±3.0%. TLDs 
were irradiated to a dose of 120 MU using 6 MV x-ray then 
irradiated to the same dose after 24 h. TLDs were irradiated 
by two 125I seeds with the same activity for 24 h, and the 
interval time was 24 h, to study the repeatability of TLDs for 
6 MV x-ray and 125I seed. TLDs were irradiated to different 
doses using 137Cs (662 keVγ-ray), 125I seed and 6 MV x-ray, to 
study the dose response of the TLDs. TLDs were irradiated to 
a dose of 1 mGy using 137Cs, 48 keV, 65 keV, 83 keV, 118 keV 
and 250 keV x-rays, to study the energy response of the TLDs. 
TLDs were irradiated to a dose of 120 MU using 6 MV x-ray 
with different dose rates of 37 MU/min, 75 MU/min, 150 
MU/min, 300 MU/min and 600 MU/min; TLDs were irradiated 
to the same dose using three 125I seeds with different 
activities of 0.739 mCi, 0.675 mCi and 0.559 mCi, and the 
irradiated time were 24 h, 26h 17 min and 31 h 48 min, 
respectively, to study the dose rate effect of TLDs for 6 MV x-
ray and 125I seed. 
Results: 350 TLD2000 TLDs were selected with the sensitivity 
within ±3.0%. The maximum deviations of the repeatability 
were 2.7% and 4.0% for 6 MV x-ray and 125I seed, respectively. 
The dose response of TLDs for 137Cs and 125I seed were linear. 
For 6 MV x-ray, the linear response range were 0.74 Gy-10.0 
Gy, beyond 10.0 Gy the dose response became supralinear 
but proportional to the absorbed dose to TLD. The energy 
response for 48 keV, 65 keV, 83 keV, 118 keV and 250 keV x-
rays, relative to the energy response of 137Cs, were 1.25, 
1.08, 0.99, 0.91 and 0.96, respectively. There were no dose 
rate effects in the dose rate range of 37 MU/min to 600 
MU/min for 6 MV x-ray and 0.66 cGy/h to 0.87 cGy/h for 125I 
seed. 
Conclusions: TLD2000 TLD has good repeatability and linear 
dose response for 137Cs, 125I seed and 6 MV x-ray without dose 
rate effect, but the dose response is energy dependent. 
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Purpose/Objective: The aim of this work was to study the 
characteristics of the ionization chamber array 1000 SRS 
(PTW) for flattening filter (FF) and flattening free filter (FFF) 
beams delivered by a True Beam STx linear accelerator 
(Varian). The array with the octavius 4D phantom was 
evaluated for pretreatment QA of FF and FFF stereotactic 
treatment plans. 
Materials and Methods: The response of the detectors to 
field size, dose linearity, and dose rate were assessed for 6 
and 10 MV FF and 6 and 10 MV FFF. Dosimetric accuracy of 
the detector array was evaluated against measurements 
made using PTW electron diode 60017 (Ediode), PTW 
microDiamond 60019 and PTW semiflex 31010 for field size 
superior to 3x3 cm². Pretreatment QA of FF and FFF 
stereotactic treatment plans were evaluated using a 3D 
gamma function with 2%/2mm tolerance. Stereotacic 
treatment plans were calculated with two treatment 
